West Pharma (WST) Tops Q1 EPS by 9c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to West Pharma (WST) Tops Q1 EPS by 9c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook

UPDATE: William Blair Starts West Pharmaceutical (WST) at Outperform

April 23, 2019 5:38 AM EDT

(Updated - April 23, 2019 6:55 AM EDT)

(updated to add analyst comments)

William Blair analyst John Kreger initiates coverage on West Pharmaceutical (NYSE: WST) with a Outperform rating.

The analyst commented, "West is a leading global designer and manufacturer of technologically advanced... More